BioCardia said its CEO will present at an investor conference. The filing attaches a press release but gives no clinical results or financing details, so it does not change the company's outlook.
BioCardia filed an 8-K saying its CEO will present at an investor conference. The filing only announces the presentation and includes no clinical results or financial updates, so I read it as neutral.
Follow BioCardia, Inc. (BCDA) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for BCDA